Atlas Trials

Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens

Clinical trial NCT06342115 · RECRUITING

Trial details

NCT number
NCT06342115
Sponsor
Beneficência Portuguesa de São Paulo
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Febrile Neutropenia
Start date
2025-03-26
Primary completion
2026-12-01
Enrollment
176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.